NCT03678883 2024-11-07
9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
GOG Foundation
GOG Foundation
UNICANCER
National Cancer Institute (NCI)
GOG Foundation